Seminars in Vascular Surgery最新文献

筛选
英文 中文
Computer Science meets Vascular Surgery: Keeping a pulse on artificial intelligence 计算机科学与血管外科:保持人工智能的脉搏
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-09-01 DOI: 10.1053/j.semvascsurg.2023.05.003
Carly Thaxton , Alan Dardik
{"title":"Computer Science meets Vascular Surgery: Keeping a pulse on artificial intelligence","authors":"Carly Thaxton ,&nbsp;Alan Dardik","doi":"10.1053/j.semvascsurg.2023.05.003","DOIUrl":"10.1053/j.semvascsurg.2023.05.003","url":null,"abstract":"<div><p><span>Artificial intelligence (AI)–based technologies have garnered interest across a range of disciplines in the past several years, with an even more recent interest in various health care<span> fields, including Vascular Surgery. AI offers a unique ability to analyze health data more quickly and efficiently than could be done by humans alone and can be used for clinical applications such as diagnosis, </span></span>risk stratification<span>, and follow-up, as well as patient-used applications to improve both patient and provider experiences, mitigate health care disparities<span>, and individualize treatment. As with all novel technologies, AI is not without its risks and carries with it unique ethical considerations that will need to be addressed before its broad integration into health care systems. AI has the potential to revolutionize the way care is provided to patients, including those requiring vascular care.</span></span></p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46546498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The regulatory environment for artificial intelligence–enabled devices in the United States 美国人工智能设备的监管环境
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-09-01 DOI: 10.1053/j.semvascsurg.2023.05.005
Nathan L. Liang , Timothy K. Chung , David A. Vorp
{"title":"The regulatory environment for artificial intelligence–enabled devices in the United States","authors":"Nathan L. Liang ,&nbsp;Timothy K. Chung ,&nbsp;David A. Vorp","doi":"10.1053/j.semvascsurg.2023.05.005","DOIUrl":"10.1053/j.semvascsurg.2023.05.005","url":null,"abstract":"<div><p>The regulatory environment in the United States has not kept pace with the rapidly developing market for artificial intelligence (AI)–enabled devices. The number of AI-enabled devices has increased year after year. All of these devices are registered or cleared by the US Food and Drug Administration through exempt or 510(k) premarket notification pathways, and the majority are related to the radiology or cardiovascular spaces. US Food and Drug Administration guidance has not yet addressed the unique challenges of AI-enabled devices, including development, comprehensibility, and continuously learning models. The liability aspects of AI-enabled devices deployed into use by clinicians in practice have yet to be addressed. Future guidance from government regulatory sources will be necessary as the field moves forward.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43104778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protecting patient safety and privacy in the era of artificial intelligence 在人工智能时代保护患者安全和隐私
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-09-01 DOI: 10.1053/j.semvascsurg.2023.06.002
Andrea Alonso, Jeffrey J. Siracuse
{"title":"Protecting patient safety and privacy in the era of artificial intelligence","authors":"Andrea Alonso,&nbsp;Jeffrey J. Siracuse","doi":"10.1053/j.semvascsurg.2023.06.002","DOIUrl":"10.1053/j.semvascsurg.2023.06.002","url":null,"abstract":"<div><p><span>The promise of artificial intelligence (AI) in health care has propelled a significant uptrend in the number of </span>clinical trials<span><span><span> in AI and global market spending in this novel technology. In vascular surgery<span>, this technology has the ability to diagnose disease, predict disease outcomes, and assist with image-guided surgery. As we enter an era of rapid change, it is critical to evaluate the ethical concerns of AI, particularly as it may impact patient safety and privacy. This is particularly important to discuss in the early stages of AI, as technology frequently outpaces the policies and ethical guidelines regulating it. Issues at the forefront include patient privacy and confidentiality, protection of patient autonomy and </span></span>informed consent, accuracy and applicability of this technology, and propagation of </span>health care disparities. Vascular surgeons should be equipped to work with AI, as well as discuss its novel risks to patient safety and privacy.</span></p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47012857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential applications of artificial intelligence and machine learning on diagnosis, treatment, and outcome prediction to address health care disparities of chronic limb-threatening ischemia 人工智能和机器学习在诊断、治疗和结果预测方面的潜在应用,以解决慢性肢体威胁性缺血的医疗保健差异。
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-09-01 DOI: 10.1053/j.semvascsurg.2023.06.003
Amir Behzad Bagheri , Mohammad Dehghan Rouzi , Navid Alemi Koohbanani , Mohammad H. Mahoor , M.G. Finco , Myeounggon Lee , Bijan Najafi , Jayer Chung
{"title":"Potential applications of artificial intelligence and machine learning on diagnosis, treatment, and outcome prediction to address health care disparities of chronic limb-threatening ischemia","authors":"Amir Behzad Bagheri ,&nbsp;Mohammad Dehghan Rouzi ,&nbsp;Navid Alemi Koohbanani ,&nbsp;Mohammad H. Mahoor ,&nbsp;M.G. Finco ,&nbsp;Myeounggon Lee ,&nbsp;Bijan Najafi ,&nbsp;Jayer Chung","doi":"10.1053/j.semvascsurg.2023.06.003","DOIUrl":"10.1053/j.semvascsurg.2023.06.003","url":null,"abstract":"<div><p><span><span>Chronic limb-threatening ischemia (CLTI) is the most advanced form of </span>peripheral artery disease. CLTI has an extremely poor prognosis and is associated with considerable risk of major amputation, cardiac morbidity, mortality, and poor </span>quality of life<span><span>. Early diagnosis and targeted treatment of CLTI is critical for improving patient's prognosis. However, this objective has proven elusive, time-consuming, and challenging due to existing </span>health care disparities<span> among patients. In this article, we reviewed how artificial intelligence (AI) and machine learning (ML) can be helpful to accurately diagnose, improve outcome prediction<span>, and identify disparities in the treatment of CLTI. We demonstrate the importance of AI/ML approaches for management of these patients and how available data could be used for computer-guided interventions. Although AI/ML applications to mitigate health care disparities in CLTI are in their infancy, we also highlighted specific AI/ML methods that show potential for addressing health care disparities in CLTI.</span></span></span></p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49684798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Mature artificial intelligence– and machine learning–enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration–approved or cleared technologies relevant to vascular surgeons 影响血管外科护理的成熟人工智能和机器学习医疗工具:美国食品和药物管理局批准或批准的血管外科医生相关技术的后期范围审查。
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-09-01 DOI: 10.1053/j.semvascsurg.2023.06.001
David P. Stonko, Caitlin W. Hicks
{"title":"Mature artificial intelligence– and machine learning–enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration–approved or cleared technologies relevant to vascular surgeons","authors":"David P. Stonko,&nbsp;Caitlin W. Hicks","doi":"10.1053/j.semvascsurg.2023.06.001","DOIUrl":"10.1053/j.semvascsurg.2023.06.001","url":null,"abstract":"<div><p><span><span>Artificial intelligence and machine learning (AI/ML)-enabled tools are shifting from theoretical or research-only applications to mature, clinically useful tools. The goal of this article was to provide a scoping review of the most mature AI/ML-enabled technologies reviewed and cleared by the US Food and Drug Administration relevant to the field of vascular surgery. Despite decades of slow progress, this landscape is now evolving rapidly, with more than 100 AI/ML-powered tools being approved by the US Food and Drug Administration each year. Within the field of vascular surgery specifically, this review identified 17 companies with mature technologies that have at least one US Food and Drug Administration clearance, all occurring between 2016 and 2022. The maturation of these technologies appears to be accelerating, with improving regulatory clarity and clinical uptake. The early AI/ML-powered devices extend or amplify clinically entrenched platform technologies and tend to be focused on the diagnosis or evaluation of time-sensitive, clinically important pathologies (eg, reading Digital Imaging and Communications in Medicine–compliant </span>computed tomography images to identify pulmonary embolism), or when physician efficiency or time savings is improved (eg, preoperative planning and intraoperative guidance). The majority (&gt;75%) of these technologies are at the intersection of </span>radiology and vascular surgery. It is becoming increasingly important that the contemporary vascular surgeon understands this shifting paradigm, as these once-nascent technologies are finally maturing and will be encountered with increasingly regularity in daily clinical practice.</p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49684761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence–based predictive models in vascular diseases 基于人工智能的血管疾病预测模型
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-09-01 DOI: 10.1053/j.semvascsurg.2023.05.002
Fabien Lareyre , Arindam Chaudhuri , Christian-Alexander Behrendt , Alexandre Pouhin , Martin Teraa , Jonathan R. Boyle , Riikka Tulamo , Juliette Raffort
{"title":"Artificial intelligence–based predictive models in vascular diseases","authors":"Fabien Lareyre ,&nbsp;Arindam Chaudhuri ,&nbsp;Christian-Alexander Behrendt ,&nbsp;Alexandre Pouhin ,&nbsp;Martin Teraa ,&nbsp;Jonathan R. Boyle ,&nbsp;Riikka Tulamo ,&nbsp;Juliette Raffort","doi":"10.1053/j.semvascsurg.2023.05.002","DOIUrl":"10.1053/j.semvascsurg.2023.05.002","url":null,"abstract":"<div><p><span><span>Cardiovascular disease represents a source of major health problems worldwide, and although medical and technical advances have been achieved, they are still associated with high morbidity and mortality rates. Personalized medicine would benefit from novel tools to better predict individual prognosis and outcomes after intervention. Artificial intelligence (AI) has brought new insights to </span>cardiovascular medicine, especially with the use of machine learning techniques that allow the identification of hidden patterns and complex associations in health data without any </span><em>a priori</em><span> assumptions. This review provides an overview on the use of artificial intelligence–based prediction models in vascular diseases, specifically focusing on aortic aneurysm<span>, lower extremity arterial disease<span><span>, and carotid stenosis. Potential benefits include the development of precision medicine </span>in patients with vascular diseases. In addition, the main challenges that remain to be overcome to integrate artificial intelligence–based predictive models in clinical practice are discussed.</span></span></span></p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43168363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex differences in outcomes of exercise therapy for patients with intermittent claudication: A scoping review 间歇性跛行患者运动治疗结果的性别差异:一项范围综述
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-08-25 DOI: 10.1053/j.semvascsurg.2023.08.001
M. Libby Weaver , Laura T. Boitano , Brian J. Fazzone , Jonathan R. Krebs , Andrea H. Denton , Pranav Kapoor , Corey A. Kalbaugh , Jessica P. Simons
{"title":"Sex differences in outcomes of exercise therapy for patients with intermittent claudication: A scoping review","authors":"M. Libby Weaver ,&nbsp;Laura T. Boitano ,&nbsp;Brian J. Fazzone ,&nbsp;Jonathan R. Krebs ,&nbsp;Andrea H. Denton ,&nbsp;Pranav Kapoor ,&nbsp;Corey A. Kalbaugh ,&nbsp;Jessica P. Simons","doi":"10.1053/j.semvascsurg.2023.08.001","DOIUrl":"10.1053/j.semvascsurg.2023.08.001","url":null,"abstract":"<div><p><span>Exercise therapy<span> is first-line treatment for </span></span>intermittent claudication<span><span> due to peripheral artery disease. We sought to synthesize the literature on sex differences in response to exercise therapy for the treatment of intermittent claudication due to peripheral artery disease. A scoping review was performed (1997 to 2023) using Ovid MEDLINE, CINAHL (Cumulative Index to Nursing and Allied Health Literature), Embase, SPORTDiscus, and Web of Science. Articles were included if they were a scientific report of any measures of health-related </span>quality of life<span> or walking performance after an intervention that included a structured walking program. Of the 13 studies, 11 included measures of walking distance; 7 included measures of walking time, 5 included measures of walking speed, and 4 included quality of life measures. Overall, exercise therapy resulted in significant improvements across most measures of walking performance for both men and females. When comparing magnitudes of outcome improvement by sex, results of walking-based measures were contradictory; some studies noted no difference and others found superior outcomes for men. Results of quality of life–based measures were also contradictory, with some finding no difference and others reporting substantially more improvement for females. Both men and females experienced considerable improvement in walking performance and quality of life with exercise therapy. Evidence regarding the differential effect of exercise therapy on outcomes by sex for intermittent claudication is limited and contradictory. Further efforts should be directed at using standardized interventions and metrics for measuring the outcomes that match the indications for intervention in these patients to better understand the expected benefits and any variance according to sex.</span></span></p></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45944735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considerations in the Application of Artificial Intelligence in Vascular Surgical Education 人工智能在血管外科教学中应用的思考
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-08-01 DOI: 10.1053/j.semvascsurg.2023.07.004
D. Rigberg, J. Jim
{"title":"Considerations in the Application of Artificial Intelligence in Vascular Surgical Education","authors":"D. Rigberg, J. Jim","doi":"10.1053/j.semvascsurg.2023.07.004","DOIUrl":"https://doi.org/10.1053/j.semvascsurg.2023.07.004","url":null,"abstract":"The rapid adoption of artificial intelligence (AI) into everyday use has presented multiple issues for surgical educators to consider. In this article, the authors discuss some of the ethical aspects of academic integrity and the use of AI. These issues include the importance of understanding the current limits of AI and the inherent biases of the technology. The authors further discuss the ethical considerations of the use of AI in surgical training and in clinical use, with an emphasis on vascular surgery.","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43684457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mature AI/ML-Enabled Medical Tools Impacting Vascular Surgical Care: A scoping review of late-stage, FDA approved/cleared technologies relevant to vascular surgeons 影响血管外科护理的成熟人工智能/机器学习医疗工具:对后期、FDA批准/清除的血管外科相关技术的范围审查
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.06.001
David P. Stonko, C. Hicks
{"title":"Mature AI/ML-Enabled Medical Tools Impacting Vascular Surgical Care: A scoping review of late-stage, FDA approved/cleared technologies relevant to vascular surgeons","authors":"David P. Stonko, C. Hicks","doi":"10.1053/j.semvascsurg.2023.06.001","DOIUrl":"https://doi.org/10.1053/j.semvascsurg.2023.06.001","url":null,"abstract":"Artificial intelligence and machine learning (AI/ML)-enabled tools are shifting from theoretical or research-only applications to mature, clinically useful tools. The goal of this article was to provide a scoping review of the most mature AI/ML-enabled technologies reviewed and cleared by the US Food and Drug Administration relevant to the field of vascular surgery. Despite decades of slow progress, this landscape is now evolving rapidly, with more than 100 AI/ML-powered tools being approved by the US Food and Drug Administration each year. Within the field of vascular surgery specifically, this review identified 17 companies with mature technologies that have at least one US Food and Drug Administration clearance, all occurring between 2016 and 2022. The maturation of these technologies appears to be accelerating, with improving regulatory clarity and clinical uptake. The early AI/ML-powered devices extend or amplify clinically entrenched platform technologies and tend to be focused on the diagnosis or evaluation of time-sensitive, clinically important pathologies (eg, reading Digital Imaging and Communications in Medicine-compliant computed tomography images to identify pulmonary embolism), or when physician efficiency or time savings is improved (eg, preoperative planning and intraoperative guidance). The majority (>75%) of these technologies are at the intersection of radiology and vascular surgery. It is becoming increasingly important that the contemporary vascular surgeon understands this shifting paradigm, as these once-nascent technologies are finally maturing and will be encountered with increasingly regularity in daily clinical practice.","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46777706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential applications of artificial intelligence (AI) and machine learning (ML) on diagnosis, treatment, outcome prediction to address health care disparities of chronic limb-threatening ischemia (CLTI) 人工智能(AI)和机器学习(ML)在慢性肢体威胁缺血(CLTI)诊断、治疗和预后预测方面的潜在应用
IF 2.5 3区 医学
Seminars in Vascular Surgery Pub Date : 2023-06-01 DOI: 10.1053/j.semvascsurg.2023.06.003
Amirbehzad Bagheri, Mohammad Dehghan Rouzi, Navid Alemi Koohbanani, M. Mahoor, MG Finco, Myeounggon Lee, B. Najafi, Jayer Chung
{"title":"Potential applications of artificial intelligence (AI) and machine learning (ML) on diagnosis, treatment, outcome prediction to address health care disparities of chronic limb-threatening ischemia (CLTI)","authors":"Amirbehzad Bagheri, Mohammad Dehghan Rouzi, Navid Alemi Koohbanani, M. Mahoor, MG Finco, Myeounggon Lee, B. Najafi, Jayer Chung","doi":"10.1053/j.semvascsurg.2023.06.003","DOIUrl":"https://doi.org/10.1053/j.semvascsurg.2023.06.003","url":null,"abstract":"Chronic limb-threatening ischemia (CLTI) is the most advanced form of peripheral artery disease. CLTI has an extremely poor prognosis and is associated with considerable risk of major amputation, cardiac morbidity, mortality, and poor quality of life. Early diagnosis and targeted treatment of CLTI is critical for improving patient's prognosis. However, this objective has proven elusive, time-consuming, and challenging due to existing health care disparities among patients. In this article, we reviewed how artificial intelligence (AI) and machine learning (ML) can be helpful to accurately diagnose, improve outcome prediction, and identify disparities in the treatment of CLTI. We demonstrate the importance of AI/ML approaches for management of these patients and how available data could be used for computer-guided interventions. Although AI/ML applications to mitigate health care disparities in CLTI are in their infancy, we also highlighted specific AI/ML methods that show potential for addressing health care disparities in CLTI.","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45834884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信